Commercial insight into the pharma and biotech sector.
Solutions for Private Equity & Venture Capital
Identifying investment opportunities in the pharma and biotech sector and effectively tracking performance, demands data and intelligence that will provide new insights and perspectives. Our trusted expertise means you can rely on EvaluatePharma throughout the lifecycle of an investment – from prospecting, to valuation of assets, appraisal of commercial prospects, creating value by actively managing the asset, right through to identifying potential purchasers and the optimum time to exit.
- Screen hundreds of small and medium sized companies for investment purposes with Peer Group Analyzer making screening by sector, market cap., and therapy area simple and fast
- Evaluate the likely performance and returns of your investment with our unique forward-looking analysis template with in-depth forecast financial models on the leading pharmaceutical and biotechnology companies
- Respond quickly to ad hoc investment proposals by analyzing multiple valuation measures and company fundamentals, creating customized reports and presentations in an instant with our powerful editing tool
- Monitor the competition to your portfolio of companies for marketed and pipeline products and define your own peer groups to track
- Model the potential impact of industry events with our cutting-edge NPV Analyzer and see how patent extension, litigation, clinical trials and product approvals may influence both product and company valuations
Find out more Download Solutions for Private Equity & Venture Capital
Register for access to a selection of free analysis and insights